SCHEMBL1528053

SCHEMBL1528053

Clc1ccccc1-c1nc[nH]n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.52
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
NR1H2 P55055 2/20 0.46
NR1H3 Q13133 2/20 0.46
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C19 P33261 2/20 0.46
TP53 P04637 2/20 0.46
HPGD P15428 2/20 0.46
ALPL P05186 1/20 0.46
CYP2C9 P11712 1/20 0.46
IDO1 P14902 1/20 0.44
DCUN1D1 Q96GG9 2/20 0.43
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 2/20 0.42
APOBEC3G Q9HC16 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL9835024 0.80 LDHA (0.36) LDHANPC1RAB9ASMN1; SMN2NR1H2
SCHEMBL2099637 0.78 IDO1 (0.48) RAB9ASMN1; SMN2CYP1A2CYP3A4CYP2D6
SCHEMBL30089883 0.77 AHR (0.41) RAB9ASMN1; SMN2HPGDALPLALDH1A1
SCHEMBL16112339 0.76 PBRM1 (0.52) NPC1RAB9ASMN1; SMN2NR1H2NR1H3
SCHEMBL10801976 0.76 DCUN1D1 (0.43) NPC1RAB9ASMN1; SMN2IDO1DCUN1D1
SCHEMBL11686059 0.76 IDO1 (0.52) NPC1RAB9ASMN1; SMN2CYP3A4HPGD
SCHEMBL15125436 0.76 GAA (0.52) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL9173243 0.76 IDO1 (0.47) RAB9ASMN1; SMN2CYP1A2CYP3A4CYP2D6
SCHEMBL1395368 0.76 IDO1 (0.48) NPC1RAB9ASMN1; SMN2HPGDIDO1
SCHEMBL626420 0.75 NR4A2 (0.36) LDHANPC1RAB9ASMN1; SMN2NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483278-A1 BENZOXAZEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE F. Hoffmann-La Roche AG (CH) 2012-08-08 EP disclosed
WO-2011036280-A1 BENZOXAZEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2011-03-31 WO disclosed
CN-1251589-A Substituted triazolopyridazine derivatives as ligands for GABA receptors MERCK SHARP & DOHME (GB) 2000-04-26 CN disclosed
EP-0915875-A2 SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME LTD. (GB) 1999-05-19 EP disclosed
WO-1998004559-A2 SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME LIMITED (GB) 1998-02-05 WO disclosed
CN-1053792-A Herbicidal compound with triazolopyridine group RHONE POULENO AGROCHIMIE (FR) 1991-08-14 CN disclosed